152 related articles for article (PubMed ID: 32506665)
1. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial.
Chadid S; Song X; Schenk JM; Gurel B; Lucia MS; Thompson IM; Neuhouser ML; Goodman PJ; Parnes HL; Lippman SM; Nelson WG; De Marzo AM; Platz EA
Nutr Cancer; 2022; 74(1):141-148. PubMed ID: 33511883
[TBL] [Abstract][Full Text] [Related]
3. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
Kristal AR; Till C; Tangen CM; Goodman PJ; Neuhouser ML; Stanczyk FZ; Chu LW; Patel SK; Thompson IM; Reichardt JK; Hoque A; Platz EA; Figg WD; Van Bokhoven A; Lippman SM; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1823-32. PubMed ID: 22879203
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
Black A; Pinsky PF; Grubb RL; Falk RT; Hsing AW; Chu L; Meyer T; Veenstra TD; Xu X; Yu K; Ziegler RG; Brinton LA; Hoover RN; Cook MB
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2374-82. PubMed ID: 25178985
[TBL] [Abstract][Full Text] [Related]
5. Selenium and Sex Steroid Hormones in a U.S. Nationally Representative Sample of Men: A Role for the Link between Selenium and Estradiol in Prostate Carcinogenesis?
Van Hemelrijck M; Sollie S; Nelson WG; Yager JD; Kanarek NF; Dobs A; Platz EA; Rohrmann S
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):578-583. PubMed ID: 30482876
[TBL] [Abstract][Full Text] [Related]
6. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
Zhou CK; Stanczyk FZ; Hafi M; Veneroso CC; Lynch B; Falk RT; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhenn IA; Levine PH; Hsing AW; Cook MB
Prostate; 2017 Dec; 77(16):1573-1582. PubMed ID: 28971497
[TBL] [Abstract][Full Text] [Related]
7. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.
Umbehr MH; Gurel B; Murtola TJ; Sutcliffe S; Peskoe SB; Tangen CM; Goodman PJ; Thompson IM; Lippman SM; Lucia MS; Parnes HL; Drake CG; Nelson WG; De Marzo AM; Platz EA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):264-9. PubMed ID: 25939516
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
9. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
11. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract][Full Text] [Related]
12. Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.
Nash SH; Schenk JM; Kristal AR; Goodman PJ; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Song X; Gurel B; De Marzo A; Platz EA
Cancer Prev Res (Phila); 2015 Jul; 8(7):590-6. PubMed ID: 25926387
[TBL] [Abstract][Full Text] [Related]
13. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
14. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
15. Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations.
Cook MB; Stanczyk FZ; Wood SN; Pfeiffer RM; Hafi M; Veneroso CC; Lynch B; Falk RT; Zhou CK; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhann IA; Levine PH; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1660-1666. PubMed ID: 28830872
[No Abstract] [Full Text] [Related]
16. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.
Peskoe SB; Joshu CE; Rohrmann S; McGlynn KA; Nyante SJ; Bradwin G; Dobs AS; Kanarek N; Nelson WG; Platz EA
Prostate; 2015 Aug; 75(11):1167-76. PubMed ID: 25919471
[TBL] [Abstract][Full Text] [Related]
17. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
18. Associations between postmenopausal endogenous sex hormones and C-reactive protein: a clearer picture with regional adiposity adjustment?
Conroy SM; Neilson HK; O'Reilly R; Woolcott CG; Stanczyk FZ; Courneya KS; Friedenreich CM
Menopause; 2017 Sep; 24(9):1040-1048. PubMed ID: 28640164
[TBL] [Abstract][Full Text] [Related]
19. Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.
Allott EH; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Cancer Prev Res (Phila); 2017 Jun; 10(6):319-326. PubMed ID: 28487295
[TBL] [Abstract][Full Text] [Related]
20. Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES.
Anic GM; Albanes D; Rohrmann S; Kanarek N; Nelson WG; Bradwin G; Rifai N; McGlynn KA; Platz EA; Mondul AM
Clin Endocrinol (Oxf); 2016 Aug; 85(2):258-66. PubMed ID: 26991691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
